Overview of the CheckMate 816 Trial

What are the latest advances in lung cancer treatment?

In April 2022, findings from the large scale CheckMate 816 clinical trial were presented to the American Association for Cancer Research. The trial looked into the effectiveness of immunotherapy drug Nivolumab, combined with chemotherapy to treat lung cancer patients. The findings were promising, showing that this particular treatment combination can delay the progression or return of cancer. 

How common is lung cancer and how does it start? What are the most prominent treatment options? Should we expect this treatment to become used widely?  ⁠In under 3 minutes, we answer your questions !⁠

To listen to the last episodes, you can click here :

⁠What is Roe vs Wade, the ruling that guaranteed American women abortion rights?⁠

⁠Could tourism quotas help preserve endangered local environments?⁠

⁠Is bikini waxing harmful for your health?⁠

A podcast written and realised by Joseph Chance.

First Broadcast: 9/7/2022

Learn more about your ad choices. Visit megaphone.fm/adchoices